Top 5 Canadian Biotech Stocks in 2025
3 Articles
3 Articles
Top 20 global biopharmaceutical companies witness 6% growth in market capitalization in Q1 2025, reveals GlobalData - GlobalData
The biopharmaceutical industry saw a strong start to 2025, despite ongoing uncertainty around the potential impact of Trump’s proposed pharmaceutical tariffs impacting global supply chains. Nevertheless, the industry remains resilient, with the top 20 biopharmaceutical companies reporting an upturn of 6% in aggregate market capitalization from $3.7 trillion as on 31 December 2024 to $3.9 trillion as on 31 March 2025, reveals GlobalData, a leadin…
Top 5 Canadian Biotech Stocks in 2025
Biotech is a dynamic industry that is driving scientific advances and innovation in healthcare. In Canada, the biotech sector is home to companies pursuing cutting-edge therapies and medical technologies. According to Grandview Research, the global biotech market is expected to grow at a compound annual growth rate of 13.96 percent between 2024 and 2030 to reach a value of US$3.08 trillion. Read on to learn what’s been driving these Canadian b…
Uncover the Best-Performing Canadian Biotech Stocks of 2025
Biotech is a dynamic industry that is driving scientific advances and innovation in healthcare. In Canada, the biotech sector is home to companies pursuing cutting-edge therapies and medical technologies. According to Grandview Research, the global biotech market is expected to grow at a compound annual growth rate of 13.96 percent between 2024 and 2030 to reach a value of US$3.08 trillion. Here the Investing News Network profiles the five bes…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage